Biologically active implants

Details Biologically active implants Biologically active implants

2006-02-14

2006-02-14

Spear, James M. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S423000

Reexamination Certificate

active

06998134

ABSTRACT:
This invention relates to an implant for treating pathological changes in the spinal column and/or locomotor system. According to one embodiment of the invention, the implant may be provided with an enamel-like or varnish-like coating up to 100 μm thick and made of a biodegradable polymer such as polylactide. This coating has an osteoinductive effect, which promotes the healing of fractures. Additional osteoinductive materials such as growth factors may be incorporated in the coating. The invention also relates to a method for producing such an implant using the following steps: preparing a dispersion of biodegradable polymers in an organic solvent; applying the dispersion on the surface to be coated; and allowing the solvent to evaporate.

REFERENCES:
patent: 4338926 (1982-07-01), Kummer et al.
patent: 4476590 (1984-10-01), Scales et al.
patent: 4563489 (1986-01-01), Urist
patent: 4610692 (1986-09-01), Eitenmuller et al.
patent: 4828563 (1989-05-01), Müller-Lierheim
patent: 4902515 (1990-02-01), Loomis et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4983581 (1991-01-01), Antoniades et al.
patent: 5108399 (1992-04-01), Eitenmuller et al.
patent: 5258034 (1993-11-01), Furlong et al.
patent: 5281419 (1994-01-01), Tuan et al.
patent: 5344654 (1994-09-01), Rueger et al.
patent: 5397572 (1995-03-01), Coombes et al.
patent: 5458653 (1995-10-01), Davidson
patent: 5466609 (1995-11-01), Siiman et al.
patent: 5492697 (1996-02-01), Boyan et al.
patent: 5502074 (1996-03-01), Cullinan et al.
patent: 5514380 (1996-05-01), Song et al.
patent: 5548035 (1996-08-01), Kim et al.
patent: 5556645 (1996-09-01), Bockman et al.
patent: 5573401 (1996-11-01), Davidson et al.
patent: 5603715 (1997-02-01), Kessler
patent: 5614496 (1997-03-01), Dunstan et al.
patent: 5635571 (1997-06-01), Frechet et al.
patent: 5645592 (1997-07-01), Nicolais et al.
patent: 5656598 (1997-08-01), Dunstan et al.
patent: 5670161 (1997-09-01), Healy et al.
patent: 5686116 (1997-11-01), Bockman et al.
patent: 5697976 (1997-12-01), Chesterfield et al.
patent: 5707877 (1998-01-01), Siiman et al.
patent: 5725491 (1998-03-01), Tipton et al.
patent: 5756145 (1998-05-01), Darouiche
patent: 5759564 (1998-06-01), Milder et al.
patent: 5770255 (1998-06-01), Burrell et al.
patent: 5824088 (1998-10-01), Kirsch
patent: 5830493 (1998-11-01), Yokota et al.
patent: 5854207 (1998-12-01), Lee et al.
patent: 5876446 (1999-03-01), Agrawal et al.
patent: 5876452 (1999-03-01), Athanasiou et al.
patent: 5906600 (1999-05-01), Bähr
patent: 5916585 (1999-06-01), Cook et al.
patent: 5916870 (1999-06-01), Lee et al.
patent: 6086908 (2000-07-01), Göpferich
patent: 6530951 (2003-03-01), Bates et al.
patent: 39 33 217 (1991-04-01), None
patent: 41 30 545 (1993-03-01), None
patent: 41 30 546 (1993-03-01), None
patent: 43 34 272 (1995-04-01), None
patent: 195 11 243 (1996-01-01), None
patent: 195 14 104 (1996-11-01), None
patent: 0 198 213 (1986-10-01), None
patent: 0 366 018 (1990-05-01), None
patent: 0 198 213 (1990-08-01), None
patent: 0 567 391 (1993-10-01), None
patent: 0 636 377 (1995-02-01), None
patent: 0 652 017 (1995-05-01), None
patent: 0 395 187 (1996-01-01), None
patent: 0 719 562 (1996-07-01), None
patent: 0 792 654 (1997-09-01), None
patent: 0 816 413 (1998-01-01), None
patent: 0 850 651 (1998-07-01), None
patent: 0 652 017 (1999-08-01), None
patent: WO 88/10123 (1988-12-01), None
patent: WO 89/04674 (1989-06-01), None
patent: WO 90/13302 (1990-11-01), None
patent: WO 91/11148 (1991-08-01), None
patent: WO 92/00110 (1992-01-01), None
patent: 93/20859 (1993-10-01), None
patent: WO 93/20859 (1993-10-01), None
patent: WO 94/03159 (1994-02-01), None
patent: WO 94/08635 (1994-04-01), None
patent: WO 95/22318 (1995-08-01), None
patent: WO 95/24211 (1995-09-01), None
patent: WO 95/34251 (1995-12-01), None
patent: WO 96/00592 (1996-01-01), None
patent: WO 96/05825 (1996-02-01), None
patent: WO 96/11403 (1996-04-01), None
patent: WO 96/18591 (1996-06-01), None
patent: WO 96/28196 (1996-09-01), None
patent: WO 96/38167 (1996-12-01), None
patent: WO 97/10849 (1997-03-01), None
patent: WO 97/24369 (1997-07-01), None
patent: WO 97/32594 (1997-09-01), None
patent: WO 97/34953 (1997-09-01), None
patent: WO 97/37848 (1997-10-01), None
patent: WO 97/38741 (1997-10-01), None
patent: WO 97/47254 (1997-12-01), None
patent: WO 98/03695 (1998-01-01), None
patent: WO 98/16268 (1998-04-01), None
patent: WO 98/19699 (1998-05-01), None
Merriam Webster's Collegiate Dictionary, 10th Edition, Copyright 1999, p. 20.
R. Herrmann et al., “Antithrombogenic Coating of Stents Using A Biodegradeable Drug Delivery Technology,”Thromb Haemost, 82: 51-57 (1999).
S. Trippel, et al., “Growth Factors As Therapeutic Agents,”The Journal of Bone and Joint Surgery, 78-A(8):1272-1285 (Aug., 1996).
K. Nakamura et al., “Local Application of Basic Fibroblast Growth Factor Into the Bone Increases Bone Mass at the Applied Site in Rabbits,”Arch Orthop Trauma surg, 115:344-346 (1996).
T. Einhorn, “Current Concepts Review Enhancementv of Fracture-Healing,”The Journal of Bone and Joint Surgery, Incorporated, 77-A(6):940-956 (Jun., 1995).
Nielsen et al., “Location injection of TGF-β Increases the Strength of Tibial Fractures in the Rat,”Acta Orthop Scand, 65(1):37-41 (1994).
M. Lind et al., “Chemotaxis of Human Osteoblasts, Effects of Osteotropic Growth Factors,”APMIS, 103:140-146 (1993).
M. Lind et al., “Transforming Growth Factor-β Enhances Fracture Healing in Rabbit Tibiae,”Acta Orthop Scand, 64(5):553-556 (1993).
J. Andrew et al., “Demonstration of TGF-β1 mRNA by In Situ Hybridization in Normal Human Fracture Healing,”Calcif Tissue Int, 52:74-78 (1993).
P. Wilton, “Treatment With Recombinant Human Insulin-Like Growth Factor I of Children With Growth Hormone receptor Deficiency (Laron Syndrome),”Acta Paediatr Suppl, 383:137-141 (1992).
J. Carpenter et al., “Failure of Growth Hormone to Alter the Biomechanics of Fracture-Healing in a Rabbit Model,”The Journal of Bone and Joint Surgery, Incorporated, 74-A(3):359-367 (Mar. 1992).
J. Hock et al., “Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae,”Endocrinology, 126(1)421-426 (1990).
J. Hock et al., “Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae,”Endocrinology, 126(1)421-426 (1990).
M. Noda et al., “In vivo Stimulation of Bone Formation by Transforming Growth Factor-β,”Endocrinology, 124(6):2991-2994 (1989).
J. Hock et al., “Insulin-Like Growth Factor I Has Independent Effects on Bone Matrix Formation and Cell Replication,”Endocrinology, 122::254-260 (1988).
A. Nilsson et al., “Effects of Unilateral Arterial Infusion of GH and IGF-I on Tibial Longitudinal Bone Growth in Hypophysectomized Rats,”Calcif Tissue Int, 40:91-96 (1987).
J. Isgaard et al., “Effects of Local Administration of GH and IGF-1 on Longitudinal Bone Growth in Rats,”The American Physiological Society, pps. E367-E372 (1986).
H. Bail et al., “Histomorphometrical Evidence for the Bone Anabolic Effect of Species Specific Growth Hormone in Distraction Osteogenesis (DO),” Intl. Soc. Fracture Repair, Mar. 1998.
H. Bail et al., “Rekombinantes Wachstumshormon beschieunigt die Kallusreifung bei der Distraktionsosteogenese”, 1998. (English translation of Abstract only).
R. Herrmann et al., “Comparison of the Thrombogenicity of Steel and Gold-Surface Coronary Stents with a Biodegradable, Drug Releasing Coating in a Human Stasis Model,” Circulation 96:4048, 1997.
R. Hermann et al., “Comparison of the Thrombogenicity of Steel and Gold-Surface Coronary Stents with a Biodegradable, Drug Releasing Coating in a Human Stasis Model,” European Heart Journal 18(152):988, 1997.
G. Schmidmaier et al., “Non-Linear Tim

Affiliated with

Also associated with

Rating

Biologically active implants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active implants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active implants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3636511